Article ; Online: ACE2 in the second act of COVID-19 syndrome: Peptide dysregulation and possible correction with oestrogen.
2021 Volume 33, Issue 2, Page(s) e12935
Abstract: Coronavirus disease 2019 (COVID-19) has become the most critical pandemic of the 21st Century and ... in the pathophysiology of coronavirus disease 2019 (COVID-19) is a topic of debate, with clinical and experimental ... the regulation of ACE2 itself by steroid hormones, to ameliorate the severity of COVID-19. ...
| Abstract | Coronavirus disease 2019 (COVID-19) has become the most critical pandemic of the 21st Century and the most severe since the 1918 influenza pandemic. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the host by binding to angiotensin-converting enzyme 2 (ACE2). The role of ACE2 in the pathophysiology of coronavirus disease 2019 (COVID-19) is a topic of debate, with clinical and experimental evidence indicating a multifaceted relationship between ACE2 activity and disease severity. Here, we review the mechanisms by which the peptidergic substrates and products of ACE and ACE2 contribute to physiological and pathophysiological processes and hypothesise how down-regulation of ACE2 by SARS-CoV-2 cellular entry disrupts homeostasis. A better understanding of the endocrinology of the disease, in particular the neuroendocrinology of ACE2 during COVID-19, may contribute to the timely design of new therapeutic strategies, including the regulation of ACE2 itself by steroid hormones, to ameliorate the severity of COVID-19. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Angiotensin-Converting Enzyme 2/metabolism ; COVID-19/metabolism ; Estrogens/therapeutic use ; Humans ; Peptides/metabolism ; Protein Binding ; SARS-CoV-2/metabolism ; COVID-19 Drug Treatment | |||||
| Chemical Substances | Estrogens ; Peptides ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) | |||||
| Language | English | |||||
| Publishing date | 2021-01-18 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review | |||||
| ZDB-ID | 1007517-3 | |||||
| ISSN | 1365-2826 ; 0953-8194 | |||||
| ISSN (online) | 1365-2826 | |||||
| ISSN | 0953-8194 | |||||
| DOI | 10.1111/jne.12935 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2634: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.